Abumiya, M., Takahashi, N., Takahashi, S., Yoshioka, T., Kameoka, Y., & Miura, M. (2021). Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy. Nature Portfolio.
Style de citation Chicago (17e éd.)Abumiya, Maiko, Naoto Takahashi, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, et Masatomo Miura. Effects of SLC22A2 808G>T Polymorphism and Bosutinib Concentrations on Serum Creatinine in Patients with Chronic Myeloid Leukemia Receiving Bosutinib Therapy. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Abumiya, Maiko, et al. Effects of SLC22A2 808G>T Polymorphism and Bosutinib Concentrations on Serum Creatinine in Patients with Chronic Myeloid Leukemia Receiving Bosutinib Therapy. Nature Portfolio, 2021.